Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Universal Technical Institute
UTI
$1.67B
| $2.37M | ﹤0.01% |
267,961
-39
| -0% | -$320 |
|
3177
ZipRecruiter
ZIP
$363M
| $2.36M | ﹤0.01% |
102,864
+5,172
| +5% | +$112K |
|
|
FNA
3178
DELISTED
Paragon 28, Inc.
FNA
| $2.35M | ﹤0.01% |
140,637
+8,335
| +6% | +$134K |
|
|
ASXC
3179
DELISTED
Asensus Surgical, Inc.
ASXC
| $2.33M | ﹤0.01% |
3,724,331
-112,273
| -3% | -$86.5K |
|
|
THRX
3180
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $2.33M | ﹤0.01% |
202,436
+10,389
| +5% | +$111K |
|
|
AOMR
3181
Angel Oak Mortgage REIT
AOMR
$223M
| $2.33M | ﹤0.01% |
142,217
+40,882
| +40% | +$676K |
|
3182
KVH Industries
KVHI
$170M
| $2.33M | ﹤0.01% |
256,192
+13,614
| +6% | +$122K |
|
3183
Radware
RDWR
$1.18B
| $2.33M | ﹤0.01% |
72,791
-1,029
| -1% | -$34.2K |
|
3184
Information Services Group
III
$232M
| $2.33M | ﹤0.01% |
341,657
+8,688
| +3% | +$61.3K |
|
|
SIEN
3185
DELISTED
Sientra, Inc.
SIEN
| $2.32M | ﹤0.01% |
104,625
+5,290
| +5% | +$145K |
|
3186
Aura Biosciences
AURA
$769M
| $2.32M | ﹤0.01% |
105,334
+3,259
| +3% | +$62.1K |
|
3187
Build-A-Bear
BBW
$433M
| $2.31M | ﹤0.01% |
126,685
+5,711
| +5% | +$108K |
|
|
SMLR
3188
DELISTED
Semler Scientific
SMLR
| $2.31M | ﹤0.01% |
46,549
+200
| +0.4% | +$13.4K |
|
3189
Viper Energy
VNOM
$14.9B
| $2.31M | ﹤0.01% |
77,975
+770
| +1% | +$21.3K |
|
|
SHCO
3190
DELISTED
Soho House & Co
SHCO
| $2.3M | ﹤0.01% |
296,782
+36,194
| +14% | +$319K |
|
|
EMKR
3191
DELISTED
Emcore Corp
EMKR
| $2.3M | ﹤0.01% |
62,204
+2,965
| +5% | +$142K |
|
3192
Alaunos Therapeutics
TCRT
$4.93M
| $2.3M | ﹤0.01% |
23,510
-360
| -2% | -$46.2K |
|
|
VIRX
3193
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.29M | ﹤0.01% |
481,725
+20,498
| +4% | +$61.8K |
|
3194
Bankwell Financial Group
BWFG
$535M
| $2.29M | ﹤0.01% |
67,692
-1,158
| -2% | -$39.4K |
|
3195
Ondas Inc
ONDS
$5.17B
| $2.29M | ﹤0.01% |
313,835
+14,242
| +5% | +$76.3K |
|
3196
Nautilus Biotechnolgy
NAUT
$115M
| $2.28M | ﹤0.01% |
526,306
+31,108
| +6% | +$128K |
|
|
NMTR
3197
DELISTED
9 Meters Biopharma
NMTR
| $2.28M | ﹤0.01% |
190,290
-2,948
| -2% | -$40.3K |
|
|
PZN
3198
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $2.28M | ﹤0.01% |
283,962
+16,836
| +6% | +$154K |
|
|
NAGE
3199
Niagen Bioscience
NAGE
$239M
| $2.27M | ﹤0.01% |
924,063
+42,795
| +5% | +$117K |
|
3200
Caesarstone
CSTE
$73.3M
| $2.27M | ﹤0.01% |
216,038
+20,313
| +10% | +$241K |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,081 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.